Skip to main content
Clinical Trials/CTRI/2015/11/006393
CTRI/2015/11/006393
Completed
Phase 4

Pharmacokinetics-Pharmacodynamics relationship of vancomycin in patients with suspected or proven Gram-positive bacterial infection admitted to medicine intensive care unit of tertiary care hospital - PK-PD

Seth GSMC and KEM Hospital mumbai0 sites15 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Seth GSMC and KEM Hospital mumbai
Enrollment
15
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 5, 2016
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Seth GSMC and KEM Hospital mumbai

Eligibility Criteria

Inclusion Criteria

  • 1\.Written, signed, dated and institutional ethics committee approved informed consent obtained from patients or legally acceptable representative before performing any screening procedures
  • 2\.Patients with suspected or proven Gram â?? positive bacterial infection

Exclusion Criteria

  • 1\.Patients with hypersensitivity to vancomycin hydrochloride or any excipients of its formulation
  • 2\.Patient receiving vancomycin therapy
  • 3\.Participation in any investigational study within 30 days prior to screening

Outcomes

Primary Outcomes

Not specified

Similar Trials